Sasmit Sarangi

891 total citations
21 papers, 577 citations indexed

About

Sasmit Sarangi is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Sasmit Sarangi has authored 21 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Sasmit Sarangi's work include Glioma Diagnosis and Treatment (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Sasmit Sarangi is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Sasmit Sarangi collaborates with scholars based in United States, India and Canada. Sasmit Sarangi's co-authors include Ambarish Pandey, Anil K. Sood, Karthik Murugiah, Divyanshu Dubey, Shiladitya Sengupta, Poulomi Sengupta, Sudipta Basu, Kartavya Sharma, Ananth K. Vellimana and Nivedita Patni and has published in prestigious journals such as Neurology, Cancer Research and Nanotechnology.

In The Last Decade

Sasmit Sarangi

20 papers receiving 559 citations

Peers

Sasmit Sarangi
Hadyn Kankam United Kingdom
Allison Rose Australia
Peruvemba Sriram United States
Mohammed Al-Hamadani United States
Kari J. Anderson United States
Ellen Jones United States
Brian McGowan United Kingdom
Casey L. Daniel United States
Tony Fouweather United Kingdom
Hadyn Kankam United Kingdom
Sasmit Sarangi
Citations per year, relative to Sasmit Sarangi Sasmit Sarangi (= 1×) peers Hadyn Kankam

Countries citing papers authored by Sasmit Sarangi

Since Specialization
Citations

This map shows the geographic impact of Sasmit Sarangi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sasmit Sarangi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sasmit Sarangi more than expected).

Fields of papers citing papers by Sasmit Sarangi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sasmit Sarangi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sasmit Sarangi. The network helps show where Sasmit Sarangi may publish in the future.

Co-authorship network of co-authors of Sasmit Sarangi

This figure shows the co-authorship network connecting the top 25 collaborators of Sasmit Sarangi. A scholar is included among the top collaborators of Sasmit Sarangi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sasmit Sarangi. Sasmit Sarangi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarangi, Sasmit, et al.. (2024). Molecular and serological detection of acute canine leptospirosis and associated predictive risk factors in and around Chennai, India. Microbial Pathogenesis. 198. 107120–107120. 1 indexed citations
2.
Sarangi, Sasmit, et al.. (2024). Occurrence of leptospirosis in dogs with renal and/or hepatic disease in Chennai, India. Indian Journal of Animal Health. Online.
3.
Donahue, John E., Heinrich Elinzano, Sasmit Sarangi, et al.. (2023). Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection. Frontiers in Neurology. 13. 1017087–1017087. 2 indexed citations
4.
Ahrendsen, Jared T., Kartik Sehgal, Sasmit Sarangi, et al.. (2021). Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma. Journal of Hematology. 10(5). 212–216. 5 indexed citations
5.
Sarangi, Sasmit, David J. Einstein, Malgorzata McMasters, et al.. (2021). Parkinsonism reversed from treatment of pineal non-germinomatous germ cell tumor. Surgical Neurology International. 12. 237–237. 1 indexed citations
6.
Sarangi, Sasmit & Eric T. Wong. (2019). HOUT-05. COMPARING OUTCOMES OF ADULT DIFFUSE MIDLINE GLIOMAS TO GLIOBLASTOMA (GBM) IN YOUNG PATIENTS. Neuro-Oncology. 21(Supplement_6). vi112–vi113. 1 indexed citations
7.
Sarangi, Sasmit, Brian Wong, & Jonathan Cahill. (2018). Clinical Episode of Aseptic Meningitis with Leptomeningeal Enhancement in Patient with Anti-MOG Antibodies (P5.420). Neurology. 90(15_supplement). 2 indexed citations
8.
Dizon, Don S., et al.. (2014). Precision medicine and personalized breast cancer: combination pertuzumab therapy. Pharmacogenomics and Personalized Medicine. 7. 95–95. 9 indexed citations
9.
Sarangi, Sasmit, et al.. (2014). The Evolving Role of Circulating Tumor Cells in the Personalized Management of Breast Cancer: From Enumeration to Molecular Characterization. Current Breast Cancer Reports. 6(3). 146–153. 8 indexed citations
10.
Pandey, Ambarish, Sasmit Sarangi, Kelly S. Chien, et al.. (2014). Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery. Nanotechnology. 25(44). 445101–445101. 20 indexed citations
11.
Mittal, Niti, et al.. (2014). Comparison of tolterodine with standard treatment in pediatric patients with non-neurogenic dysfunctional voiding/over active bladder: a systematic review.. PubMed. 57(4). 343–53. 12 indexed citations
12.
Pandey, Ambarish, Ashish Kulkarni, Bhaskar Roy, et al.. (2013). Sequential Application of a Cytotoxic Nanoparticle and a PI3K Inhibitor Enhances Antitumor Efficacy. Cancer Research. 74(3). 675–685. 27 indexed citations
13.
Sarangi, Sasmit, et al.. (2013). P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer. Medical Oncology. 30(2). 567–567. 24 indexed citations
14.
Sarangi, Sasmit, et al.. (2013). PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic. Cellular Oncology. 36(6). 449–457. 26 indexed citations
15.
Pandey, Ambarish, et al.. (2012). Smartphone Apps as a Source of Cancer Information: Changing Trends in Health Information-Seeking Behavior. Journal of Cancer Education. 28(1). 138–142. 170 indexed citations
16.
Pandey, Ambarish, Sasmit Sarangi, Bhaskar Roy, et al.. (2011). Abstract B221: Clopidogrel augments cisplatin cytotoxicity by enhancing delivery and direct receptor mediated effects.. Molecular Cancer Therapeutics. 10(11_Supplement). B221–B221. 2 indexed citations
17.
Sarangi, Sasmit, K.H. Reeta, Amit Kumar Dinda, & Y.K. Gupta. (2010). Protective effect of mycophenolate mofetil on mercuricchloride-induced nephrotoxicity in rats. Methods and Findings in Experimental and Clinical Pharmacology. 32(4). 219–219. 2 indexed citations
18.
Sood, Anil K., Sasmit Sarangi, Ambarish Pandey, & Karthik Murugiah. (2010). YouTube as a Source of Information on Kidney Stone Disease. Urology. 77(3). 558–562. 180 indexed citations
19.
Srivastava, Anurag, Anil K. Sood, Parijat S. Joy, et al.. (2010). Principles of Physics in Surgery: The Laws of Mechanics and Vectors Physics for Surgeons—Part 2. Indian Journal of Surgery. 72(5). 355–361. 31 indexed citations
20.
Pandey, Ambarish, Nivedita Patni, Sasmit Sarangi, et al.. (2009). Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India. Tobacco Induced Diseases. 5(1). 15–15. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026